Identification of cerebrospinal fluid pharmacodynamic biomarkers and molecular correlates of brain activity in a Phase 2 clinical trial of the Alzheimer's disease drug candidate CT1812 is a research paper published in Alzheimer s & Dementia Translational Research & Clinical Interventions (2025). On theSindex it has a DataRank of 0. It has been cited 2 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institute on Aging
Grant: RF1AG058710
National Institutes of Health
Grant: 1RF1AG058710-01A1
A Pilot Electroencephalography (EEG) Study to Evaluate the Effect of CT1812 Treatment on Synaptic Activity in Subjects with Mild to Moderate Alzheimerʼs Disease
FWCI
0.84
Citation Percentile
0.7%
Citation Trend
Fields of Study
Keywords
Sustainable Development Goals